Approval · Notice of Compliance 15205 · 2014
REGULAR IBUPROFEN: Notice of Compliance 15205
Issued February 6, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15205
- Date
- February 6, 2014
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Additional product name
- Therapeutic class
- Non-steroidal anti-inflammatory drug, analgesic, antipyretic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REGULAR IBUPROFEN | 02420120 | Cancelled Pre Market |
| EXTRA STRENGTH IBUPROFEN | 02420139 | Cancelled Pre Market |